Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Exacerbations and Real-world Outcomes (EROS) Among Patien... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Exacerbations and Real-world Outcomes (EROS) Among Patients With COPD Receiving Single Inhaler Triple Therapy of Budesonide/glycopyrrolate/formoterol Fumarate
0
Authors
Michael Pollack
11 more
Michael Pollack
•
J.P. Tkacz
9 more
•
C. Strange
Published
May 1, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Topics
Medicine
Internal Medicine
Physical Therapy
Glycopyrrolate
Formoterol Fumarate
Show all topics
DOI
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6019
